Your Cart is Empty
Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.
GLP-1 is crucial for blood sugar control, boosting insulin release and supporting glucose balance. Lower GLP-1 levels can disrupt these processes, causing insulin resistance and elevated blood sugar. Taking a statin alongside a medication like Ozempic may diminish some of its intended effects, especially those related to managing blood sugar.
The study consisted of 30 participants, taking the drug atorvastatin. They were monitored for four months with various controls. While cholesterol levels dropped as anticipated, blood sugar slightly increased, insulin resistance worsened, and GLP-1 levels decreased by nearly 50%.
The study revealed that statins modify the gut microbiome, particularly reducing Clostridium bacteria, which produce UDCA, a bile acid that supports GLP-1 production. With reduced microbes, UDCA levels dropped, leading to lower GLP-1. Essentially, statins disrupted a gut microbial pathway critical for blood sugar regulation.
Many doctors prescribe statins without discussing their impact on insulin resistance or overall metabolic health. For patients managing cholesterol and blood sugar, this overlooked connection is vital.Â
Lifestyle interventions are indeed critical as a first-line approach to support and maintain metabolic health, especially for individuals on statins. Prioritizing lifestyle changes can enhance the effectiveness of statins, potentially reduce reliance on medication, and improve overall health.
To view the original scientific study click below:
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
Living bacteria could become the next frontier in cancer treatment. Researchers have discovered an amphibian gut bacterium that wiped out solid tumors in mice with a single dose, pointing to a potential therapy that targets tumors directly rather than simply changing the gut microbiome.
The foods consumed during pregnancy may influence more than just a baby’s growth. High consumption of fructose from sugary foods and drinks during pregnancy has been associated with increased risks of diabetes and heart-related problems in mothers. Now, new research suggests that a diet high in fructose may affect brain development, potentially causing biological changes that could impact learning and cognitive function later in the child’s life.
Healthy aging isn't just about living longer, it’s about staying strong enough to enjoy those extra years. New research shows that getting enough protein and combining it with resistance exercise is one of the most effective ways to preserve muscle, maintain mobility, and reduce the physical decline that often comes with aging.